Non-Cirrhotic Portal Hypertension
Showing 1 - 25 of >10,000
Intrahepatic Non Cirrhotic Portal Hypertension Trial in Clichy (Apixaban, Placebo)
Recruiting
- Intrahepatic Non Cirrhotic Portal Hypertension
- Apixaban
- Placebo
-
Clichy, FranceBeaujon hospital
Mar 21, 2022
Portal Hypertension, Non-Cirrhotic Portal Hypertension, Non-Cirrhotic Portal Fibrosis Trial in Rio de Janeiro (Hepatic vein
Not yet recruiting
- Portal Hypertension
- +9 more
- Hepatic vein pressure gradient measurement
- +2 more
-
Rio de Janeiro, RJ, BrazilHospital Universitário Clementino Fraga Filho / Universidade Fed
Jan 30, 2023
Pathological Spectrum of Porto-sinusoidal Vascular Disease in
Recruiting
- Portal Hypertension
- +6 more
-
Sector-12, Chandigarh, IndiaDr. Madhumita Premkumar
Sep 19, 2023
Portal Hypertension in Patients With CVID (CVID-pHT)
Recruiting
- Non-Cirrhotic Portal Hypertension
- Common Variable Immunodeficiency
- Ultrasound including color doppler ultrasound
-
Freiburg, GermanyUniversity Medical Center Freiburg, Department of Medicine II
Nov 21, 2023
Liver Cirrhosis, Portal Hypertension, Non-Cirrhotic Portal Hypertension Trial in Freiburg (Implantation of a transjugular
Recruiting
- Liver Cirrhosis
- +5 more
- Implantation of a transjugular intrahepatic portosystemic shunt (TIPS)
-
Freiburg, GermanyUniversity Medical Center Freiburg, Department of Medicine II
Mar 22, 2023
Natural History of Noncirrhotic Portal Hypertension
Recruiting
- Cystic Fibrosis
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 27, 2022
Cystic Fibrosis Liver Disease, Portal Hypertension Due to Cystic Fibrosis (Disorder), Portal Hypertension, Noncirrhotic Trial
Completed
- Cystic Fibrosis Liver Disease
- +2 more
- TIPS
- (no location specified)
Aug 30, 2021
Portal Hypertension, Portal Vein Thrombosis, Esophageal Varix Bleeding Trial in Chengdu (preemptive TIPS, standard second
Not yet recruiting
- Portal Hypertension
- +3 more
- preemptive TIPS
- standard second prophylaxis
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Nov 3, 2023
The vPPG-detecting Software Guided Management of Cirrhotic
Active, not recruiting
- Portal Hypertension
- Cirrhosis, Liver
- PPG-detecting software
- LSM and PLT count
-
Shanghai, ChinaShanghai Tongji Hospital, Tongji University School of Medicine
May 13, 2022
Vascular Liver Disease, Portal Vein Thrombosis, Budd-Chiari Syndrome Trial in Vienna
Recruiting
- Vascular Liver Disease
- +5 more
-
Vienna, AustriaMedical University of Vienna
Oct 31, 2020
Cirrhotic Patients Undergoing Liver Transplantation
Completed
- Liver Transplantation
- +3 more
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal (CHUM)
Jul 21, 2022
Portal Hypertension in Cirrhosis Based on Metabolomics
Not yet recruiting
- Cirrhosis, Liver
- Portal Hypertension
- Metabolites and HVPG
- (no location specified)
Sep 20, 2022
Portal Hypertension, Liver Cirrhosis Trial in United States (Ifetroban, Placebo)
Portal Hypertension Using Magnetic Resonance Elastography
Completed
- Portal Hypertension
- Magnetic Resonance Imaging
- MRE
-
Wŏnju, Gangwon, Korea, Republic ofWonju Severance Christian Hospital
Feb 28, 2023
PADUA PREDICTION SCORE in Cirrhotic Patients
Recruiting
- Portal Thrombosis
-
Roma, ItalyFondazione Policlinico Gemelli IRCCS
Mar 16, 2023
A Novel Spleen-dedicated Stiffness Measured by FibroScan to
Not yet recruiting
- Portal Hypertension
- Hepatic venous pressure gradient
-
Hangzhou, China
- +2 more
Sep 12, 2021
Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular
Recruiting
- Cirrhosis
- +3 more
- Apixaban 2.5 MG
- +2 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College, Yangzhou University
Apr 30, 2022
Hepatocellular Carcinoma(HCC), Cirrhotic Portal Hypertension Trial in GuangZhou (Precise hepatectomy, Combined intervention
Completed
- Hepatocellular Carcinoma(HCC)
- Cirrhotic Portal Hypertension
- Precise hepatectomy
- Combined intervention (chemoembolization/ablation)
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 20, 2021
Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)
Recruiting
- Cirrhosis
- +3 more
- Apixaban
- +4 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College of Yangzhou University
Mar 19, 2022
Recurrence of Thrombosis or Thrombotic Extension, in Event of
Completed
- Portal Vein Thrombosis
- Local Cause
-
Caen, Calvados, FranceChu de Caen
Apr 29, 2022
Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)
Not yet recruiting
- Hepatocellular Carcinoma
- Portal Hypertension
- TACE ± Systemic therapy
-
Nanjing, China
- +1 more
Jan 28, 2023
Cirrhosis, Liver, Portal Hypertension Trial in Beijing, Shanghai (Carvedilol)
Recruiting
- Cirrhosis, Liver
- Portal Hypertension
-
Beijing, Beijing, China
- +5 more
Jan 26, 2022
Relevance of Sarcopenia in Advanced Liver Disease
Recruiting
- Liver Cirrhosis
- +3 more
-
Linköping, SwedenDepartment of gastroenterology and hepatology
Aug 12, 2022
The Precise Selection of Stent Diameter for Portal Hypertension
Recruiting
- Compensated Advanced Chronic Liver Disease
- Portal Hypertension
- a non-invasive technology to evaluate hepatic venous pressure gradient and portal pressure gradient
-
Hangzhou, ChinaFirst Affiliated Hospital of Zhejiang University
Mar 17, 2022
Portal Hypertension, Chronic Advanced Liver Disease Trial in Indianapolis (Liver Incytes)
Recruiting
- Portal Hypertension
- Chronic Advanced Liver Disease
- Liver Incytes
-
Indianapolis, IndianaIndiana University Division of Gastroenterolgy and Hepatology
Jan 25, 2022